scispace - formally typeset
A

Anna Charalambous

Researcher at University of Cyprus

Publications -  25
Citations -  2137

Anna Charalambous is an academic researcher from University of Cyprus. The author has contributed to research in topics: Medicine & Antigen. The author has an hindex of 11, co-authored 19 publications receiving 2019 citations. Previous affiliations of Anna Charalambous include Rockefeller University.

Papers
More filters
Journal ArticleDOI

In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

TL;DR: By better harnessing the immunizing functions of maturing dendritic cells, antibody-mediated antigen targeting via the DEC-205 receptor increases the efficiency of vaccination for T cell immunity, including systemic and mucosal resistance in disease models.
Journal ArticleDOI

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

TL;DR: The uptake of human myeloma cells by dendritic cells after tumor cell death by bortezomib leads to the induction of antitumor immunity, including against primary tumor cells, without the need for any additional adjuvants.
Journal ArticleDOI

Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder.

TL;DR: Haplotype transmission comparisons point to a functionally distinct BDNF haplotype uniquely marked by the rare Met66 allele, which is undertransmitted and likely confers a protective effect in OCD and other psychiatric disorders.
Journal ArticleDOI

The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen

TL;DR: It is found that encapsulated Streptococcus pneumoniae are rapidly cleared by these macrophages from the bloodstream, and that capture also takes place when different cell lines express SIGN-R1 after transfection.
Journal ArticleDOI

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells

TL;DR: Mature tumor capturing DCs stimulated the differentiation of P1A tumor antigen-specific, CD8+ T cells and uniquely transferred tumor resistance to naive mice, and the access of dying tumor cells to DCs that are maturing to activated NKT cells efficiently induces long-lived adaptive resistance.